Following the decision of the PRAC of EMA, the Director General of AIFA and the president of the CSS Franco Locatelli
hanno tenuto una conferenza stampa per chiarire all’opinione pubblica la decisione di EMA, ratificata da AIFA.
This age restriction is explained by the fact that the serious cases of blood clotting problems that had motivated the suspension of the vaccine were observed only in people under the age of 55, specified the French health authority.
Per il vaccino AstraZeneca si tratta di una decisione piuttosto sorprendente, considerando che, quando è stato aperto al pubblico, soltanto 3 mesi fa, era riservato a chi ha meno di 65 anni. “L’età – ha spiegato Dominique Le Guludec, la presidente della HAS – è il fattore principale di rischio che espone le persone a sviluppare forme gravi” di Covid.
Italy has not chosen this path: “National regulatory authorities have their own degree of autonomy to decide restrictions on use. We have evaluated and do not believe that there are reasons to proceed with a restriction on the use of the AstraZeneca vaccine under the age of 55 as decided in France "said the president of the CSS Franco Locatelli during the press conference at the ministry, underlining that the majority of vaccinations with AstraZeneca were done in this age group and it is therefore consequential that the rare events reported occurred in this group. (Huffingtonpost – 19 marzo 2021)
Summary of product characteristics
Related news: Covid-19 : HAS recommends using the vaccine from AstraZeneca over 55 years and more
Caricando il video, l’utente accetta l’informativa sulla privacy di YouTube.
Find out more